HighTower Advisors
ACUR

HighTower Advisors’s Acura Pharmaceuticals ACUR Stock Holding History

HighTower Advisors’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,120
Closed -$8K – 1802
2015
Q1 		$8K Buy
2,120
+120
+6% +$383 ﹤0.01% 1598
2014
Q4 		$5K Hold
2,000
– – ﹤0.01% 1585
2014
Q3 		$8K Hold
2,000
– – ﹤0.01% 1526
2014
Q2 		$11K Hold
2,000
– – ﹤0.01% 1585
2014
Q1 		$15K Buy
+2,000
New +$17.4K ﹤0.01% 1511

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
IB
Intrust Bank Wichita, Kansas $1.23B AUM 26.34% 1-Year Est. Return

HighTower Advisors's ACUR Position: Q2 2015 in Review

HighTower Advisors sold out of Acura Pharmaceuticals (ACUR) in Q2 2015, closing a stake of 2,120 shares — an estimated $8K sold.

HighTower Advisors first reported a position in ACUR in Q1 2014 and held it in 5 quarters. The position peaked at $15K in Q1 2014. 27 funds tracked by Wall St. Rank hold ACUR as of Q2 2015.

  • HighTower Advisors reported no remaining Acura Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • HighTower Advisors sold 2,120 Acura Pharmaceuticals shares in Q2 2015, an estimated $8K.
  • HighTower Advisors first reported a position in Acura Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • HighTower Advisors's Acura Pharmaceuticals position peaked at $15K in Q1 2014.
  • 27 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2015.

Based on HighTower Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.